Thank you for signing upDear Reader, A Note Concerning Privacy, Spam, Filters, BlackLists, and Whitelists… You also might be wondering how we’re going to use your e-mail address. Please note that the security and privacy of your e-mail address is assured. We will NEVER sell or rent your e-mail address under any circumstance. Additional information can be found on our Privacy Policy. Additionally, in light of today’s use of spam filters and blacklists, we strongly encourage you to “whitelist” us to ensure that your E-Letter is delivered without fail.. Thanks for joining us. It’s an exciting time here at Fleet Street Publications and you couldn’t have joined at a better point. To ensure that you receive all our tips, tools and advice we will be sending you an email to confirm your email address. It should be arriving in your inbox shortly and all you need to do is click on the confirmation link. You’ll also hear from me from time to time. I’ll keep you updated on the latest opportunities and promotions, their support helps keep our e-letter free. And when our newest research and content is available online, I’ll be the first to let you know. Best regards,
Annabel Koffman |
Antimalaria drug reduces diabetes risk in arthritis patients
Health Bytes | 22 March, 2009 | Hot Topics:
Ever heard of off-off Broadway shows in New York City? The ones that really don't have much to do with “Broadway” at all?
Well, medicine has its own version: “off-off label” uses for drugs.
You see, there's regular “off-label,” where a drug is used to treat something other than the condition it's intended for. And then there's “off-off label,” like the kind I read about in a recent article: "Antimalarial drug prevents diabetes in arthritis patients, study suggests."
In this latest example, researchers discovered that patients being treated with the anti-malaria drug hydroxychloroquine (HCQ) for cases of rheumatoid arthritis (off label use No.1) also had a 53% lower risk of developing diabetes.
Basically, I'd define “off-off label” as a completely convoluted way to treat a patient. Unfortunately, mainstream medicine doesn't share my opinion. The lead researcher of the study I mentioned above presented his findings at the Annual Scientific Meeting of the American College of Rheumatology last October, and he concluded,"We should revisit HCQ in the treatment of rheumatoid arthritis because, in addition to its disease- modifying properties, it might prevent the development of diabetes in this high-risk group."
Enjoying this article? Sign up for our free daily email, Health Bytes, to receive urgent health breakthroughs delivered to your inbox every weekday. Sign up to Health Bytes.
Editors note
Antoinette Pombo
Health Bytes Editor
"Bringing you a constant flow of breakthrough information about natural and safe alternatives to prescription drugs"
Thanks to one heroic doctor, we now have astonishing new answers...
Health Bytes and Dr Jonathan V. Wright, MD, will help you keep yourself and your family healthy by the safest and most effective means possible. Every week you¹ll receive a constant flow of information about natural and safe alternatives to prescription drugs.
